Physician profile
Jeffrey Wayne Bragg
NPI 1518937697
$1,682.44
in general payments reported to CMS, 2019-2025
14 companies · $37.40 in 2025
The $37.40 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $64.95 · 2021: $381 · 2022: $450 · 2023: $164 · 2024: $294 · 2025: $37.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $371.21 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $364.47 | 2021-2022 | |
| Abbvie INC. | $334.74 | 2021-2024 | |
| Lilly USA, LLC | $120.85 | 2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $120.62 | 2024-2025 | Airsupra |
| Axsome Therapeutics, INC. | $116.05 | 2024 | Auvelity |
| Biohaven Pharmaceutical Holding Company LTD. | $85.63 | 2022 | |
| Amgen INC. | $67.16 | 2022 | |
| Glaxosmithkline, LLC. | $26.86 | 2024 | Shingrix, Arexvy |
| Ironshore Pharmaceuticals INC. | $16.93 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.18 | 2024 | |
| Corium, LLC | $14.96 | 2023 | Azstarys |
| Alkermes, INC. | $14.54 | 2023 | Vivitrol |
| Exact Sciences Corporation | $13.24 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Bragg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.